Nanobots Therapeutics is a biotech company focused on developing and commercializing MotionTx platform.

MotionTx technology enables the development of nanobots: unique therapeutic entities that penetrate tissues with superior efficacy, enhancing drug accumulation in target cells.  

Nanomol Technologies is both a Drug Delivery and a GMP certified Contract Analysis partner for pharmaceutical and biotech industries.

Our DELOS nanoformulation technology enables the development of  value-added medicines with enhanced efficacy, selectivity and reduced side-effects.

We provide value to companies who require appropriate characterization of critical quality attributes such as particle size, morphology and structural properties of both drug substance and drug products.

NEMA HEALTH is a preclinical stage biotech company that is developing a therapeutic vaccine for cancer treatment with main focus on advance melanoma and expanding to other types of cancer. 

A family of immunoestimulatory in-licensed peptides is the core technology behind the therapeutic vaccine.

Neurotechnology company that turns brain signals into actionable data,  developing EEG hardware, biosignal processing tools, and neuroscience services that help pharma and biotech partners measure what's happening in the brain, objectively and at scale

At Nostrum Biodiscovery, we aim to accelerate drug discovery, molecular design and engineering through computational technologies. We develop AI-driven molecular modeling technology and make the most of quantum mechanics and high-performance computing to provide faster, more cost-effective and accurate solutions for biotech and pharma companies. We help researchers and R&D teams tackle challenges across nucleic acids therapeutics, targeted protein degradation, small molecule drug discovery and antibody design, reducing the need for experimental validation while accelerating the development of innovative therapies. Our proprietary in silico screening and biophysical simulation platforms enable clients to design better drugs, optimize formulations, and streamline the development pipeline. In short, we bridge the gap between computation and experimental validation to accelerate smarter therapeutic development. With Nostrum, you design better, fail less, and move faster.

Novella is a non-invasive tool for evaluating blood flow in hepatopancreatobiliary and transplant surgeries. Our software allows surgeons and their teams to predict surgical outcomes before the first incision, leading to better results, greater safety, and a reduction in complications and associated costs up to 500%.

Novepa Therapeutics es una spin-off de la UAM y 4Ammonium Biotech que desarrolla una nueva terapia cardiovascular basada en LPC-EPA, una molécula fosfolipídica diseñada para mejorar la eficacia del EPA en combinación con estatinas. Su misión es elevar el potencial terapéutico del EPA para reducir el riesgo cardiovascular residual en pacientes con ASCVD.

Nuage Therapeutics is pioneering a novel drug discovery approach which allows the targeting of intrinsically disordered proteins (IDPs). Our mission is to deliver a new wave of transformational precision therapies for aggressive cancers. Nuage's pioneering approach enables the development of innovative therapies against cancer-driving transcription factors.